Gyrodyne, LLC 2025 Annual Report: Critical Insights for Investors

Overview

Gyrodyne, LLC (“Gyrodyne” or the “Company”) has released its Annual Report for the year ended December 31, 2025. The Company is undergoing a strategic process of liquidation, focusing on maximizing value through entitlement and sale of its two remaining real estate assets: Flowerfield and Cortlandt Manor. This report contains a number of significant updates and risk factors that shareholders and investors must closely examine.

Key Strategic and Financial Highlights

• Net Asset Value & Shareholder Distributions: As of December 31, 2025, the Company reported net assets of \$25.9 million, translating to an estimated distribution of approximately \$11.76 per common share. This is down from \$13.91 per share in 2024, reflecting ongoing costs and the challenges in asset disposition.
• Liquidation Strategy: Gyrodyne is actively pursuing entitlements for its Flowerfield and Cortlandt Manor properties. The aim is to sell these assets at enhanced values to developers, followed by the dissolution of the Company and distribution of proceeds to shareholders.
• Cash Position and Capital Needs: Management projects that additional capital will be required to fund operations through 2028, the anticipated completion date of the liquidation process. This may be achieved via property sales, modification of existing loans, or new credit facilities. There is no guarantee these measures will be successful.
• Competitive Landscape: Gyrodyne faces stiff competition in both tenant attraction and property sales from well-capitalized real estate investors, institutions, and REITs.
• SEC Compliance and Reporting: The Company continues to file all required reports and disclosures with the SEC and maintains transparency with shareholders through public filings and its website.

Risks and Uncertainties

• Entitlement and Sale Delays: Any delays or denials in securing necessary entitlements (zoning, land use, environmental, etc.) could significantly impact the value and timing of asset sales. Higher-than-expected entitlement or capital improvement costs could further erode shareholder distributions.
• Financing and Liquidity Risks: The Company’s ability to fund operations and complete its liquidation depends on modifying or securing new financing. Adverse developments in the financial sector, such as tightening credit conditions, rising interest rates, or banking crises, could jeopardize these efforts.
• Share Price Volatility & Trading Risks: Gyrodyne’s shares are thinly traded, leading to potential volatility and liquidity risks. Delisting from Nasdaq remains a risk if trading volumes fall further, which could restrict shareholders’ ability to sell shares.
• Proxy Contests and Activist Shareholders: In June 2025, Star Equity Fund, LP (holding 7.1% of shares) notified its intent to nominate two directors. Proxy contests can increase costs, create uncertainty, distract management, and potentially impede the Company’s liquidation strategy. A board change could trigger contractual obligations and impact execution of the current plan.
• Real Estate Market Risks: The value and saleability of assets depend on market conditions, interest rates, tenant stability, and economic cycles. Macroeconomic factors such as high interest rates, recession risks, and COVID-19’s lingering effects may impact asset values and timelines.
• Healthcare Sector Exposure: The Cortlandt Manor property’s value is closely tied to the healthcare sector, which faces regulatory uncertainty, changing reimbursement models, and competition from hospitals and other providers.
• Potential Shareholder Liability: If the Company’s reserves are inadequate to cover creditor claims, shareholders could be liable up to the amount distributed to them.
• Uncertain Timing and Amount of Distributions: Distributions are subject to asset sale results, entitlement success, unforeseen costs, litigation, tax audits, and other factors. There is no guarantee on the timing or amount of future distributions.

Historical and Potential Future Distributions

Gyrodyne has not paid regular dividends. Only special distributions have been made in recent years, specifically: \$9.25 per share in June 2016, \$1.50 per share in September 2016, and \$1.00 per share in July 2017. Future distributions are expected to be from asset sale proceeds or liquidation only.

Other Noteworthy Matters

• Environmental Review: Management is not aware of any environmental conditions likely to have a material effect on financial results, but changes in law or unforeseen contamination could create future liabilities.
• Legal and Compliance Matters: The Company is involved in ongoing legal processes (e.g., Article 78 Proceeding) related to entitlements, which may prolong liquidation and increase costs.
• Uninsured Risks: Some potential losses may not be covered by insurance, which could impact net proceeds.

Conclusion: Price Sensitive and Shareholder Relevance

The 2025 Annual Report presents several issues of critical importance for shareholders and investors:

• Ongoing uncertainty regarding the value and timing of future distributions.
• High dependency on securing entitlements and completing asset sales at or above target prices.
• The real possibility of additional capital needs and financing risks through 2028.
• The risk of proxy contests and activist intervention affecting strategic direction and execution.
• Thin trading volume and the risk of Nasdaq delisting, which could further depress share liquidity and value.

Any significant developments in these areas—successful or failed asset sales, entitlement outcomes, capital raising, board composition changes, or major real estate market shifts—could materially move the share price. Investors should watch for news on asset dispositions, loan modifications, proxy outcomes, and macroeconomic events that may impact Gyrodyne’s liquidation timeline and distribution amounts.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should conduct their own research and consult with professional advisors before making investment decisions. The information is based on the Company’s 2025 Annual Report, and actual results may differ due to a variety of risks and uncertainties as outlined above.

View Gyrodyne, LLC Historical chart here